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Abstract
Mycobacterium ulcerans is the causative agent of Buruli ulcer, a tropical skin
disease that affects thousands of individuals annually. Recent studies have revealed that
lipolytic enzymes are involved in the pathogenicity processes of mycobacterium and
could be potential targets for novel antibiotics. LipN is one proposed serine hydrolase in
Mycobacterium ulcerans that contains the conserved α/β hydrolase protein fold and
utilizes the conserved catalytic traid of serine, histidine, and aspartate/glutamate. The
physiological substrate and biological role of LipN from M. ulcerans have not yet been
determined. In this study, LipN was cloned into a pET28a plasmid and overexpressed in
an E. coli host. Ni-affinity chromatography was used to purity LipN from the E. coli
host cell lysate. The substrate specificity of LipN was elucidated using enzymatic
assays utilizing a library of 15 latent fluorophore substrates. Steady state kinetic data
was fit to the Michaelis-Menten equation; kcat, KM, kcat/KM were derived to quantitate the
structure-activity relationships that provide insight into the substrate specificity of
LipN. The LipN protein showed preference for 2-4 carbon chains with the highest
catalytic efficiency (kcat/KM of 881±64 M-1s-1) for an alky ether ester substrate.
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Introduction
Background and Literature Review
Mycobacterium ulcerans (M. ulcerans) is the bacterium responsible for the
infectious disease Buruli ulcer, which effects between 5,000-6,000 individuals
annually1. Buruli ulcer is an ulcerative skin disease mainly targeting children under the
age of 15 who live in Africa, South America, and the Western Pacific regions1,2,3. It is
the third most common mycobacteriosis in humans after tuberculosis and leprosy3.
Untreated, Buruli ulcer infection can lead to long-term functional disabilities or death.
The method by which Buruli ulcer is transmitted remains poorly understood and there is
currently no vaccination available; treatment is centered on early detection and
combinations of broad range antibiotics (such as rifampicin and streptomycin)1,2,3.
Unfortunately, many of the anti-mycobacterial drugs currently available do not inhibit
latent mycobacteria or drug-resistant strains1,4,5,.
Mycobacterial lipolytic enzymes and their involvement in the virulence and
pathogenicity processes of mycobacterium have recently received attention6,7,8.
Lipolytic enzymes are abundant in mycobacteria, where they mediate necessary cellular
functions such as protein recycling, cell membrane synthesis, and signaling6,7. Thus,
mycobacterial lipase enzymes appear to be viable drug targets6,7,8. Serine hydrolases are
a class of lipase enzymes that share a common chemical mechanism; they hydrolyze a
carboxylic ester to an alcohol and carboxylate using a catalytic triad of residues: serine,
histidine, and aspartate/glutamate6.7,9 (Figure 1). One proposed serine hydrolase in
Mycobacterium ulcerans is LipN.
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Figure 1: Serine hydrolases catalyze the hydrolysis of a carboxylic ester to an
alcohol and carboxylate using a catalytic triad of residues: serine, histidine, and
aspartate/glutamate. (a) an ester substrate enters the active site of the enzyme. The
nucleophilic serine is activated by proton relay involving an acidic residue and a
basic histidine residue. The activated serine residue attacks the carbonyl carbon of
the ester substrate. (b) Formation of the tetrahedral intermediate followed by its
collapse, releasing the alcohol product and forming an acyl-enzyme intermediate. (c)
A nucleophilic water molecule attacks the carbonyl of the acyl-enzyme
intermediate, forming a second tetrahedral intermediate. (d) The second tetrahedral
intermediate collapse, releasing the carboxylic acid product and regenerating the
nucleophilic serine9,10.

The genome of Mycobacterium ulcerans has been sequenced11 and includes a
DNA sequence that codes for the LipN protein14. However, basic biochemical
properties of the LipN enzyme from M. ulcerans have not been characterized and the
three-dimensional structure has not been experimentally determined. The natural
physiological substrate and biological role of the LipN enzyme are unknown.
Homologs of the LipN protein in other organisms have been identified and
characterized. Of particular interest is the recent characterization of LipN (Rv2970c) of
Mycobacteria tuberculosis12. Jadehi et al. characterized LipN (Rv2970c) of M.
tuberculosis and its probable role in xenobiotic degradation. The enzyme showed
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preference for short chain carbon substrates with no positional specificity and was
inhibited with Tetrahydrolipstatin, RHC-80267, and N-bromosuccinimide (Figure 2).
The active site residues were confirmed to be Ser216, Asp316, and His346 and the
enzymatic activity was shown to be dependent on the non active site Trp145 residue.
The LipN sequence of M. tuberculosis exhibited high identity (38%) with hHSL family
enzymes and contains all the same conserved motifs. Jadehi et al. suggested that LipN
from M. tuberculosis functions as an arylesterase in the bisphenol A degradation
pathway, converting 4-HPS to hydroquinone12 (Figure 3).
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Figure 2: Chemical structures of the inhibitors Tetrahydrolipstatin, RHC-80267, and Nbromosuccinimide12.
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Figure 3: Proposed reaction scheme showing 4-hydroxyphenylacetate hydrolase activity
of LipN from Mycobacterium tuberculosis12.
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BLAST sequence alignment revealed that the LipN protein from M. ulcerans
shows high sequence identity (72%) to the LipN protein from M. tuberculosis (Figure
4). Based on the sequence similarity, it can be predicted that the overall structure and
active site of the two LipN proteins are quite alike. Therefore, characterizing LipN from
M. ulcerans will provide structural insights for other mycobacterial lipolytic enzymes,
especially other mycobacterial LipN proteins. On an applied scale, characterizing LipN
from M. ulcerans could aid in the rational design of inhibitors targeting the LipN
enzyme, and thus potential anti-mycobacterial drugs13.

Figure 4: BLAST protein sequence alignment of the expressed amino acid sequence of
LipN of M. ulcerans. Query sequence is LipN of M. ulcerans and subject sequence is
LipN of M. tuberculosis; alignment is shown in between the query and subject
sequence. There is a 72% identity between the two sequences.
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Fortunately, the Seattle Structural Genomics Center for Infectious Disease has
cloned LipN sequence from M. ulcerans into a plasmid vector containing a histidine tag
as part of larger project aimed at identifying and characterizing biomedical relevant
drug targets, enzymes, and virulence factors of infectious diseases14.
Objective
My research aims to gain a better understanding of the substrate specificity of
the serine hydrolase LipN from M. ulcerans by measuring its enzymatic activity using a
library of latent fluorophore ester substrates.
Significance
No scientific articles focused on the characterization of LipN from M. ulcerans
have been published, so all of my findings represent new contributions to the
understanding of this enzyme. My research provides data of basic biochemical interest;
clues to the identity of the physiological substrate and the biological role for the LipN
enzyme in M. ulcerans. On a global scale, this data may contribute to the rational design
of inhibitors targeting the LipN enzyme, and thus potential anti-mycobacterial drugs.
Central Methodology: Enzymatic Assays using Latent Fluorophore Substrates
A prerequisite to establishing an enzyme’s true activities and physiological
function is biochemical characterization using specific substrates7. An accurate
enzymatic assay is essential for the analysis of the substrate specificity and binding
affinity of an enzyme. The enzymatic assay employed in this study makes use of small
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fluorescent molecular dyes as substrates to quantitate the kinetic activity of a given
hydrolysis reaction.
Fluorescent dyes are invaluable tools for understanding biological processes,
specifically, they facilitate studies of reaction kinetics and binding affinity15. These
fluorescent compounds and their derivatives are useful as substrates for bacterial
enzymes such as esterases and serine hydrolases based on their selective fluorescent
properties15,16,17.
The relative rate of hydrolysis of a series of fluorogenic ester substrates, as
catalyzed by LipN, was the primary method by which I studied the structure-activity
relationship that revealed clues to the substrate specificity of LipN. The hydrolysis
reaction converts a non-fluorescent starting material into a fluorescent product, called
fluorescein (Figure 5A)16,17. This reaction is negligibly slow in the absence of a
catalyst16,17. The LipN enzyme catalyzes this hydrolysis reaction, so the rate of
appearance of fluorescence is dependent upon the efficiency of catalysis by LipN. This
basic hydrolysis reaction can be measured for various esters, whose structures share the
same aromatic core but include variable acyl groups (Figure 5B)16,17. The reaction
catalyzed by LipN was measured under steady state conditions, meaning the
concentration of the substrate will be much higher than the concentration of the catalyst
and only the initial reaction rate rather than the entire time course of the reaction was
measured.
The previously synthesized Butler library of latent fluorophores was used to
study the activity of LipN esterase in order to better understand the binding affinity of
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the enzyme as well as potentially provide insight to the physiological role of the enzyme
(Figure 5)16,17,18,19,20.
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Figure 5: LipN catalyzed hydrolysis of various latent fluorogenic ester substrates. (A)
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LipN converts the fluorescein core from the nonfluorescent lactone to the fluorescent
quinoid form, fluorescein. (B) Fluorogenic substrate library of the 15 acyl R-groups.
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Data analysis of Enzymatic Assays
As a common practice, the catalytic activity of enzymes is quantitated using two
parameters: KM and kcat. KM indicates the binding affinity of the substrate to the
enzymatic protein and kcat represents the maximum catalytic rate or in other words, the
rate by which the substrate is converted to the product. The values of KM and kcat are
dependent on the chemical identity of the fluorogenic substrate in the hydrolysis
reaction (figure 5)10,17,18,19,20. The KM and kcat values are obtained by fitting the
hyperbolic rate data to the Michaelis-Menten equation10:

Observed steady state rate =

!!"# × Enzyme ×[substrate]
!! + [substrate]

Fitting the hyperbolic rate data to the Michaelis-Menten equation also gives
VMAX, which is the maximum rate at which the enzyme is saturated with substrate9. KM
is calculated by finding the substrate concentration at which VMAX is at half of its
value9. The efficiency at which LipN catalyzes the hydrolysis reaction was quantitated
as the kcat/KM ratio to derive the global structural and functional relationship between
LipN and the various acyl groups tested. The enzyme is expected to show preference for
some acyl groups over others, and therefore catalyze reactions with variable efficiency
depending on the specificity with which the enzyme binds the various substrates.
Substrates that are more efficiently hydrolyzed by LipN are assumed to bear acyl
groups that more closely resemble the true physiological substrate for the LipN enzyme
in M. ulcerans18,19,20.
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Error Analysis of Enzymatic Assays
The error associated with the values for VMAX and KM were calculated using
Origin Software based on the rate data fit to the hyperbolic Michaelis-Menten curve.
The error for the kcat and kcat/KM values were derived according to the following
equations10:
!!"# error =

!!"#
!!"#
error =
!!
!!

!!"# error
[Enzyme]

!!"# error
!!"#

!

!! error
+
!!

!

Materials and Methods
Molecular Cloning
The gene coding for LipN was previously cloned into an AVA0421 vector,
which is a derivative of pET12b bacterial expression vector, by Seattle Structural
Genomics Center for Infectious Disease (SSGCID)14 but failed to properly overexpress.
The LipN gene was removed from the AVA0421 vector and cloned into a pET28a
plasmid® following the Novagen pET System Manual Protocol21.
A double digest using the restriction endonucleases Xba1 and Xho1 was
performed for AVA0421 and pET28 vectors in 37°C water bath for 2 hours. Samples
were then placed in 65°C hot bath for 20 minutes to denature the restriction enzymes.
The ligation reaction of the double digested vectors (5µL) was performed with
T4 ligase (2µL), ATP (2µL), and T4 ligase buffer (5µL) in a thermo cycler for 12 hours
at 15°C.
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Samples of the digest reaction (5µL) and undigested reaction (5µL) with 6X
Gel-loading dye (5µL) were analyzed on 0.8% agarose gel run in Tris/Acetate/EDTA
buffer (132V; 45min.) and stained with ethidium bromide for 15 min. The gel was
visualized using a Proteinsimple FluoroChem Q imager.
Bacterial Transformation into the E. coli strain DH5α
An aliquot of the ligation mixture (10µL) was added to DH5α E. coli cells and
incubated on ice for 30mins. The cells were heat shocked for 40 seconds in 42°C water
bath and immediately placed back on ice for 2min. The transformed cells were
transferred to a glass culture tube with 1mL of liquid LB media and shaken at 225 rpm
for 1 hour at 37°C. The cells were then incubated at 37 °C overnight on LB-Kanamycin
plates.
Miniprep
The LipN plasmid was purified from E. coli using an IBI High-Speed Plasmid
Mini Kit22. Transformed E. coli cultures were centrifuged (16,000 x g; 1 min.) and the
supernatant was discarded. The cell pellet was resuspended using PD1 Buffer, followed
by vortexing (200 µL, buffer contains RNase). Bacterial cells were lysed (200 µl of PD2
Buffer) and incubated at room temperature until the lysate was homogenous (2 min).
Cells were neutralized (300 µl of PD3 Buffer) and immediately inverted 10 times
followed by centrifugation (16,000 x g; 3 min.). Supernatant, containing the plasmid
DNA, was added to PD column and centrifuged (16,000 x g; 30 sec.). The column was
washed (W1 Buffer; 400 µl) followed by centrifugation (16,000 x g; 30 sec.). Wash
Buffer was added into PD column (600 µl) and centrifuged (16,000 x g; 30 sec.). The
PD column and collection tube was centrifuged for 16,000 x g and 3 min. to remove
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residual ethanol. Plasmid DNA attached to the DNA affinity column was incubated at
room temperature for 5 min., and then eluted with 50µl ddH2O followed by
centrifugation (16,000 x g; 2 min.).
DNA Concentration
The DNA concentration of the purified plasmid was determined via ultraviolet
absorption spectroscopy using a Synergy H1 Hybrid reader with a Take3 microplate and
analyzed through Gen5 program (240-300nm). Four samples of 2 µL were analyzed
with respect to water.
Sequence Analysis
Purified plasmid samples (10µL) of adequate DNA concentration were sent for
sequencing at Genewiz. The T7 forward and T7 reverse primers were used to evaluate
the LipN gene sequence. The results were examined using the Expasy translate
program, protein BLAST, and BioEdit Sequence Alignment Editor. The Expasy
translate program was used to convert DNA sequence to protein sequences, and protein
BLAST was used to analyze the alignment of the protein sequence with the wild-type
LipN sequence. The BioEdit Sequence Alignment Editor used both the reverse and
forward sequences to reconstruct the full LipN gene and compare the LipN sequence in
the pET28a plasmid to the wild-type LipN sequence.
Bacterial Transformation into E. coli strains BL21(DE3)RIPL and
BL21(DE3)pLysS
The pET28a plasmid was transformed into the protein expression strains
BL21(DE3)RIPL and BL21(DE3)pLysS of E. coli. The pET28a plasmid (3 µL) was
added to BL21(DE3)RIPL and BL21(DE3)pLysS E. coli cells and incubated on ice for
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30 mins. The cells were heat shocked for 40 seconds in 42 °C water bath and
immediately placed back on ice for 2 min. The transformed cells were transferred to a
glass culture tube with 1 mL of LB media and shaken at 225 rpm for 1 hour at 37 °C.
The BL21(DE3)RIPL cells were then incubated at 37 °C overnight on LB-KanamycinChloramphenicol plates and the BL21(DE3)pLysS on LB-Kanamycin plates.
IPTG Induced Overexpression of pET28a plasmid
Starter cultures of 5mL of LB-chloramphenicol-kanamycin for BL21(DE3)RIPL
transformed cells and LB-Kanamycin for BL21(DE3)pLysS transformed cells were
grown to saturation. The starter cultures were used to seed 250 mL cultures of LB with
the appropriate antibiotics for both E. coli strains and grown to the optimum growth
density of 0.8 with shaking at 225 rpm, 37 °C. Cultures were then cooled to 18°C and
inducted with 250 µl of Isopropyl β-D-1thiogalactopyranoside (IPTG) and shaken
overnight (225 rpm, 18°C). Cultures were then pelleted by centrifugation (16,000 x g,
10 mins, 4°C) and samples of 20 µl of both strains where taken to analyze the
overexpression.
Protein Purification
The pelleted 250 mL cultures of both transformed E. coli strains were suspended
in 3.0mL of 10X phosphate buffered saline solution (PBS) with 75 mg/mL of lysozyme
and 800µL of 10X BugBuster. The solutions were placed on a rotor and lysed for 4
hours at 10°C. The lysed bacteria were centrifuged (16,000 x g, 5min) at 10 °C and a
sample of the supernatant (40 µL) was transferred and stored for SDS-PAGE gel. The
pellet was discarded. Nickel-NTA agarose resin (500 µL) was added to the remaining
supernatant and the mixture was placed on the rotator (10 °C, for 45 min) to allow the
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protein to bind to the nickel resin. The resin with protein bound was collected by
centrifugation (2,000 x g, 2 min, 10 °C), and the flowthrough (40 µL) was saved for
SDS-PAGE. The resin was resuspended and washed in PBS +10mM imidazole (3X at
1.5mL each) and then recollected through centrifugation (2,000 xg, 15sec, RT). The
resin was then washed with increasing concentrations of imidazole (PBS + 25mM
imidazole; 2X at 1.5 mL each and PBS + 50mM imidazole; 2X at 1.5 mL each) and
samples were collected for SDS-PAGE after each initial wash. The bound LipN enzyme
was eluted in 600 µL of PBS + 250 mM imidazole by allowing the solution to sit on ice
for 10 min while being inverted every minute followed by centrifugation (16,000 x g, 1
min, 4 °C). Eluted protein (600 µL) was dialyzed in PBS buffer at 4 °C for two days.
SDS-PAGE
IPTG induced overexpression samples, protein purification samples, and
purified LipN protein samples were analyzed using a pre-poured SDS-PAGE gel (420% gradient) and run at 180 V for 45 min in 1X tris-glycine buffer. Samples were
prepared with 6X SDS loading dye and heated at 95°C for 10min to denature the
proteins. The gel was stained with colloidal coomassie brilliant blue for 24 hr and
destained for 24 hr before imaging.
Protein Concentration
The concentration of LipN in solution was quantitated by ultraviolet light
absorption spectroscopy (Synergy H1 Hybrid reader with take3 microplate), using the
theoretical extinction coefficient for LipN of Σ280 = 4.2 x 104 M-1cm-1 based upon its
amino acid sequence. PBS dialysis buffer (2 µL) was used as the baseline for the UV
reading. Protein samples of 2µL were analyzed in duplicates. The instrument utilizes the
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Beer-Lambert equation to correlate the absorbance at 280 nm with the concentration of
the protein based on the theoretical extinction coefficient.
Thermal Stability
The thermal stability of the protein was measured using differential scanning
fluorimetry23,24 at a concentration of 0.3mg/mL. The thermal stability samples were
prepared in a 96 well plate by adding 3.33µl of LipN protein, 1µl of Sypro Orange dye,
and 20.67µl of 1X PBS. Each sample was run in triplicate using the Bio-rad C1000
Thermocycler with CFX96 Real-time system which heats the samples from 15°C to
95°C at 1°C/min.
Enzyme Kinetics
Enzymatic activity of LipN was measured using Fluorogenic hydrolase
substrates in a 96-well microplate assay. The fluorogenic substrates were synthesized as
previously reported16,17,18,20. The substrates were stored as a 10 mM stock solution in
DMSO and diluted with PBS containing acetylated BSA (0.1 mg/mL) to an initial
concentrations of 100 µM. Eight serial dilutions were prepared for each substrate in
triplicate using PBS-BSA (1:3; 60 µL into 180 µL total volume). Eight serial 1:2
dilutions of the fluorescein standard in PBS-BSA was prepared from a stock solution of
300nM of fluorescein in 10% DMSO. Substrate dilutions of 95 µL were then transferred
to a black 96-well microplate. The LipN protein (5 µL of 300 µg/mL) was then added to
the diluted Fluorogenic substrates to initiate the hydrolysis reaction (final protein
concentration 15 µg/mL; final volume 100 µL). The fluorescence change (λex= 485 nm,
λem=520 nm) was measured using a Synergy H1 Hybrid fluorescent plate reader and
then converted to molar concentrations using the standard fluorescein curve. The initial
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rates of the hydrolysis reaction were plotted against the Fluorogenic substrate
concentrations and then the saturation enzyme kinetic data was fit to a standard
Michaelis-Menten equation using Origin software. The enzymatic activity of LipN with
each substrate was calculated by the Michaelis-Menten values kcat, KM, and kcat/KM.

Results and Discussion
Molecular Cloning and Sequencing
The gene coding for LipN was previously cloned into pET14 plasmid but failed
to properly overexpress. It was speculated that the pET14 plasmid failed to show proper
overexpress because of an issue with the T7 promoter or stop codon however, this was
never confirmed. Using the restriction sites Xba1 and Xho1 the LipN sequence was
removed from the pET14 plasmid and cloned into the pET28a plasmid.
The LipN DNA encoded in pET28 plasmid was transformed into DH5α E. coli
cells using the antibiotics Kanamycin and chloramphenicol as selective markers. The
plasmid was then isolated and purified from E. coli cell contents using alkaline lysis in
conjunction with DNA affinity columns. The DNA concentration of the purified
plasmid was then analyzed and pooled together and diluted to approximately 70 ng/µL
using deionized water (Table 1A and B). The molecular cloning of the LipN sequence
into the pET28a plasmid vector was confirmed via sequencing. T7 forward and T7
reverse primers were used and the sequencing results were evaluated using Expasy
translate and BLAST (Figure 6). The sequence showed a 100% match to lipase from
Mycobacterium, confirming the LipN sequence. The experimental LipN sequence
showed a 100% match to the theoretical LipN amino acid sequence from the pET14
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plasmid purchased from The Seattle Structural Genomics Center for Infectious
Disease13 (Figure 6).
Table 1A: Average DNA concentrations of LipN plasmid.
Sample DNA concentration (ng/µL)
1
175.4
2
179.9
3
110.1
4
73.7
Table 1B: Average DNA concentrations of pooled and diluted LipN plasmid samples.
Sample DNA concentration (ng/µL)
1
75
2
73

FCLTLRRRYTMAHHHHHHMGTLEAQTQGPGSMTNSLPGETDLHPETVHATMS
WLSRVQNTVTVVGAKVIPWVPDVAKRLITRGRSVIIDGNTLDPALQLMLSGMR
VVGLDGLVIDDDLAASRAHMREAMLGFPGPQIHVDVEELTLPGPAGDISARHY
RPPGDAAAPLLVFYHGGGWALGDLDTHDAVCRLTCRDAGIHVLAIDYRLSPEH
RAPAAIDDAFAAFEWAHAHAAELGALPGRVAVGGDSAGGNLAAVVSQLARDS
GGPAPIFQWLIYPRTDFAGRTRSASLFARGFLLTKRDIDWFHSQYLKGSGIEPTD
PRVSPLRAESLAGLAPALIAVAGFDPLRDEGENYATALRAAGTPVDLRAMGSL
THGFLNLFPLGGGCAAATSELISALRAHLTRV--TARTSSAAKLLEHHHHHHDPAANKA
Figure 6: Expasy translate results of the overlap of the T7 forward and T7 reverse
primer of the LipN pET28a plasmid. The LipN amino acid sequence is shown in red.
Purification and IPTG Induced Overexpression
The cloned M. ulcerans LipN protein was overexpressed in E. coli host (strain
BL21-DE3) grown under selective pressure using chloramphenicol and kanamycin
antibiotic, and induced with isopropylthiogalactiside (IPTG). The LipN protein was
purified from other E. coli soluble components via Ni-NTA affinity chromatography
and eluted with increasing concentration of imidazole followed by dialysis against
phosphate-buffered saline solution. The identity and purity of the LipN protein was
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confirmed by sodium Dodecyl Sulfate-PolyAcrylamide Gel Electrophoresis (SDSPAGE).
SDS-PAGE is used to confirm the presence of a protein based on the expected
molecular weight and allows for detection of any protein contaminants left over from
the E. coli host cells. The expected molecular weight for the cloned LipN protein is 41.7
kD based on the amino acid sequence. The SDS-PAGE gel showed a large band around
40 kD, which corresponds to the expected molecular weight of the LipN protein,
confirming the successful overexpression and identity of the LipN protein. The only
other visible band appears around 14kDa, which is the molecular weight of lysozyme.
This impurity was most likely left over from the lysis of the cultured E. coli cells.
Overall, the SDS-PAGE gel confirmed the presence of a relatively pure solution
of LipN protein (Figure 7).

Figure 7: SDS-PAGE of LipN induced with IPTG. The two important lanes are labeled;
the standard marker with the corresponding molecular weight values and the LipN
protein sample. The overexpressed LipN band appears around 40kDa corresponding to
the predicted molecular weight of 41.7kDa for the cloned LipN protein. The only other
band, 14kDa, is predicted to be lysozyme.
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Protein Concentration
The concentration of LipN in solution was quantitated by ultraviolet light
absorption spectroscopy, using the theoretical extinction coefficient for LipN of Σ280 =
4.2x104 M-1cm-1. The purified LipN protein has an average concentration of 2.25
mg/mL (Table 2).
Table 2: Protein Concentration of LipN quantitated by ultraviolet light absorption
spectroscopy.
Sample Protein Concentration (mg/mL)
1
2.07
2
2.43
Average
2.25
Thermal Stability
The thermal stability of LipN was measured by differential scanning fluorimetry
using SYPRO orange dye25. The midpoint of the thermal denaturation curve (Tm value)
was measured in triplicate and each value yielded a melting temperature of 43°C
(Figure 8). Based on the thermal stability it can be predicted that the LipN protein will
not denature during the kinetic assays that were ran at 24°C.
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Figure 8: Thermal Stability assay of LipN using differential scanning fluorimetry. The
relative fluorescent units (RFU) are plotted against temperature. The unfolding of the
LipN protein and exposure of buried hydrophobic areas leads to increased binding of
SYPRO Orange dye. The Tm value is the midpoint of the protein unfolding transition
and was calculated in triplicate as depicted by the three separate melting curves25. The
Tm value for LipN was calculated to be 43.0°C.
Substrate Specificity of LipN
An approach to gaining a comprehensive understanding of enzymes such as
LipN is through analyzing the enzyme’s substrate specificity and binding affinity
through a highly accurate enzymatic assay. The substrate specificity of LipN was
elucidated by the relative rate of hydrolysis of the library of Fluorogenic esters
catalyzed by LipN. The hydrolysis reaction converts a non-fluorescent ester substrate
into a fluorescent product, fluorescein. The reaction is negligibly slow in absence of a
catalyst and the rate of appearance of fluorescence is dependent on the efficacy of
catalysis with a given substrate.
The overall efficiency at which LipN catalyzed the hydrolysis reaction for the
latent fluorogenic ester substrates (Figure 5) was quantitated as the kcat/KM ratio. The
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LipN enzyme showed the highest enzymatic activity for substrate number 6,
di(methoxyacetoxymethyl ether), yielding a kcat/KM ratio of 881 M-1s-1. The high overall
enzymatic activity of LipN with substrate 6 is based more on the efficiency of the
enzyme than the binding interactions. LipN catalyzed substrate 6 with the greatest
efficiency (kcat = 3.6 × 10!! s-1) but relatively weak binding interactions (KM = 4.1 M)
compared to the other fluorogenic ester substrates (Table 3).
The enzyme showed some activity on the alkyl ester substrates 2 (kcat/KM = 140
M-1s-1), 3 (kcat/KM = 89 M-1s-1), and 4 (kcat/KM ratio = 87M-1s-1), implying that LipN
prefers two to four carbon chain alkyl ester substrates. The bulky cycloalkyl esters,
tertiary ester, unsaturated ester, and fluorinated esters were poor substrates based on
their low enzymatic activity with the exception of the fluorinated ester substrate 15 and
the cycloalkyl ester substrate 9.
Substrate 9, di(cyclobutanecarboxymethyl ether), and substrate 15,
di(trifluoropropionoxymethyl ether), where the exceptions to the general tend and
yielded a kcat/KM ratio of 48 M-1s-1and 80 M-1s-1 respectively. Substrate 9 is the least
bulky compared to the other cycloalkyl ester substrates and the unsaturated and tertiary
ester, implying that the enzyme is inefficient at hydrolyzing substrates having larger,
bulky acyl R groups but is able to hydrolyze smaller cycolalkyl ester substrates. The
binding interactions of substrate 9 and substrate 6 were similar, KM = 4.2 M and KM =
4.1 M respectively, but the catalytic efficiency of LipN was lower for substrate 9, kcat =
2.0 × 10!! s-1. Aside from preferring short chain, non-bulky ester derivatives, the LipN
enzyme seems to have greater catalytic efficiency with substrates containing a
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heteroatom. This assumption was further verified by analysis of the overall catalytic
efficiency of LipN with the fluorinated ester substrates.
LipN showed minuscule enzymatic activity for the bulky fluorinated ester
substrates 13 and 14; however, LipN catalyzed the non-bulky fluorinated ester substrate
15 with overall efficiency close to that of the alkyl ester substrates 3 and 4. Substrate 15
yielded a kcat/KM of 80 M-1s-1, substrate 3 yielded a kcat/KM of 89 M-1s-1, and substrate 4
yielded a kcat/KM of 87 M-1s-1(Table 3). Although the overall catalytic efficiency of
LipN for substrates 2, 3, and 15 is similar there are deviations between the kcat and KM
values.
The alkyl ester substrates gave small kcat and KM values suggesting that LipN
catalyzes the substrates with low efficiency but forms strong binding interactions.
Listed in numerical order starting with substrate 2: kcat 1.3 × 10!! s-1, KM = 0.9 M; kcat
3.3 × 10!! s-1, KM = 0.37 M; kcat 5.8 × 10!! s-1, KM = 0.7 M. Conversely, LipN showed
to form weak binding interactions (KM = 30 M) with the fluorinated ester substrate 15
but higher catalytic efficiency (kcat = 2.4 × 10!! s-1) compared to the alkyl ester
substrates 2 and 3. Comparing substrate 15 (a two carbon fluorinated ester) to substrate
2 (a two carbon alky ester) we can deduce the relative effect of the fluorine on the
catalytic activity of LipN. The fluorine atom decreased the binding interaction, as seen
by a larger KM value, but increased the catalytic efficiency (kcat) of the enzyme (Table
3).
Overall, LipN prefers non-bulky 2-4 carbon chain substrates. The highest overall
catalytic efficiency was seen for the alkyl ether ester substrate 6. LipN showed some
enzymatic activity for the alkyl ester substrates 2, 3, and 4, which formed strong
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binding interactions but yielded low catalytic efficiency. The enzymatic activity seen
with substrate 9 and substrate 15 indicate that the enzyme is more efficient at catalyzing
the hydrolysis of a short carbon chain ester substrate that contains a heteroatom.

A

1000

Alkyl Esters

Cycloalkyl Esters

F

1: R =

900

9: R =

kcat/Km (M-1 s-1)

F

F
F

13: R =

2: R =

800

Fluorinated Esters

F
10: R =

3: R =

700

F
F
14: R =

4: R =

600

F

11: R =

F
F

5: R =

500

15: R =

CF3

12: R =

400

Alkyl Ether Ester

300

6: R =

Unsaturated Ester

Tertiary Ester

7: R =

8: R =

O

200
100
0

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15

Fluorogenic Substrate

Stephanie N. Raynor 29

kcat/Km (M-1 s-1)

150
100
50
0
1

kcat/Km (M-1 s-1)

8

2
3
4
5
Fluorogenic Substrate

D

C

60
40
20
0

9

-20

100
80
60
40
20
0

6
4
2
0
7
8
Fluorogenic Substrate

10

11

12

Fluorogenic Substrate

kcat/Km (M-1 s-1)

kcat/Km (M-1 s-1)

B

E

13
14
15
Fluorogenic Substrate

Figure 9: (A) Overall catalytic efficiency (kcat/KM) of LipN with each of the 15 latent
fluorogenic substrates with the chemical identity of the acyl R-groups. To show patterns
within the different classes of substrates, important subclasses are compared: (B) alkyl
esters (C) cycloalkyl esters (D) unsaturated ester and tertiary ester (E) fluorinated esters.
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Table 3: Michaelis-Menten constants: KM, kcat, kcat/KM for the library of 15 Latent
fluorogenic ester substrates with error analysis.
Substrate
kcat (s-1)
KM (M)
kcat/KM (M-1s-1)
1
0.58 ± 0.14
21 ± 2
1.2 × 10!! ± 7 × 10!!
!!
!!
2
0.9 ± 0.24
140 ± 18
1.3 × 10 ± 7 × 10
3
0.37 ± 0.06
89 ± 5
3.3 × 10!! ± 9 × 10!!
!!
!!
4
0.7 ± 0.2
87 ± 5
5.8 × 10 ± 3 × 10
!!
!!
5
3.8 ± 0.7
2 ± 0.2
7.7 × 10 ± 3 × 10
!!
!!
6
4.1
±
0.6
881 ± 64
3.6 × 10 ± 2 × 10
7
7±3
2.1 × 10!! ± 1 × 10!!
3.7 ± 0.8
!!
!!
8
10.6 ± 0.5
7.2 ± 0.1
7.9 × 10 ± 1 × 10
!!
!!
9
4.2 ± 0.5
48 ± 2
2.0 × 10 ± 5 × 10
10
29 ± 4.6
3.9 ± 0.3
1.1 × 10!! ± 7 × 10!!
11
11.9 ± 5.4
1±2
1.3 × 10!! ± 2 × 10!!
!!
!!
12
-0.12 ± 0.02
-1 ± 0.7
2 × 10 ± 8 × 10
13
4.2 × 10!! ± 2 × 10!! 0.125 ± 0.005
3 ± 0.1
!!
!!
14
188 ± 49
2.3 × 10 ± 4 × 10
1.2 ± 0.3
!!
!!
15
30 ± 11
80 ± 22
2.4× 10 ± 3 × 10
Conclusion
Mycobacterium ulcerans is the causative agent of the ulcerative skin disease
Buruli ulcer, which currently has limited treatment options available. Lipolytic enzymes
have been shown to be potential drug targets based on their prevalence in mycobacteria
and importance in mediating necessary cellular functions. LipN is one proposed serine
hydrolase of M. ulcerans that has gained recent attention in the scientific literature. The
natural physiological substrate and biological role of the LipN protein has not been
revealed. Therefore, studies focused on analyzing the structure-function relationship of
the LipN enzyme provide data of basic biochemical interest. Throughout Butler
Summer Institute and my senior year at Butler University, I investigated the substrate
specificity of the LipN enzyme by measuring its enzymatic activity against a library of
15 latent fluorophore ester substrates. Steady state enzymatic kinetic data was fit to the
Michaelis-Menten equation; kcat, KM, kcat/KM constants were derived to quantitate the
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structure-activity relationships that will provide insight into the substrate specificity of
LipN.
The LipN protein showed preference for non-bulky 2-4 carbon chains with the
greatest enzymatic activity for an alky ether ester substrate with a kcat/KM of 881±64 M1 -1

s . The affect of heteroatoms on the overall catalytic activity of the LipN enzyme is

not fully understood. Heteroatoms may increase the catalytic efficiency of the enzyme
but reduce the binding interactions between the enzyme and the substrate. This pattern
was seen for substrate 6 and substrate 15, both of which are short chain carbon
substrates with a heteroatom. These two substrates showed the greatest catalytic
efficiency out of all the substrates tested, yielding a kcat = 3.6 × 10!! s-1 and kcat =
2.4× 10!! s-1, respectively. However, the binding interactions of substrate 6 (KM = 4.2
M) and substrate 15 (KM = 30 M) were weak. Expansion of the substrate library to
include short carbon chains containing heteroatoms is needed to gain a full
understanding of the effect heteroatoms have on the enzymatic activity of LipN.
Future studies will be directed at gaining a more holistic understanding of the
substrate specificity of the LipN enzyme by using additional latent fluorophore
substrates: specifically, substrates with short carbon chains containing heteroatoms.
Site-directed mutagenesis of the proposed active site residues would also help to reveal
the structure-function relationship of the LipN protein. Furthermore, crystalizing the
LipN protein will provide a more global understanding of the structure of LipN and will
allow for more detailed structural comparisons between the LipN protein of M. ulcerans
and the LipN protein of other mycobacteria.
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Appendix A
Fluorescein di(acetoxymethyl ether) ACME
Substrate #1
Gener

O

O

O

O

O
O
O

Chi2/DoF

8.2483E-8

R2

0.96207

VMAX

0.004

+0.0002

KM (M)

0.58

+0.14

Kcat (s-1)

0.000012

+4.7E-07

O
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Fluorescein di(propionoxymethyl ether) PRME
Substrate #2

O

O

O

O

O
O
O

Chi2/DoF

0.00001

R2

0.95583

VMAX

0.038

+0.002

KM (M)

0.9

+0.24

Kcat (s-1)

0.000125

+7E-06

O
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Fluorescein di(butyloxymethyl ether) BUME
Substrate #3

O

O

O

O

O
O
O

Chi2/DoF

3.7464E-7

R2

0.98163

VMAX

0.0119

+0.00034

KM (M)

0.37

+0.06

Kcat (s-1)

3.3E-5

+9E-7

O
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Fluorescein di(valeryloxymethyl ether) VLME
Substrate #4

O

O

O

O

O
O
O

Chi2/DoF

2.3786E-6

R2

0.95067

VMAX

0.0174

+0.0009

KM (M)

0.7

+0.2

Kcat (s-1)

5.8.3E-5

+3E-6

O
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Fluorescein di(hexanoylxymethyl ether) HXME
Substrate #5

O

O

O

O

O
O
O

Chi2/DoF

2.081E-8

R2

0.98343

VMAX

0.0028

+0.0001

KM (M)

3.8

+0.7

Kcat (s-1)

7.7E-6

+3E-7

O
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Fluorescein di(methoxyacetoxymethyl ether) MOAME
Substrate #6

O

O

O

O

O

O

0.00217

R2

0.99176

VMAX

1.31

+0.06

KM (M)

4.1

+0.6

Kcat (s-1)

3.6E-3

+2E-4

O
O

O

Chi2/DoF

O
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Fluorescein di(methacryloxymethyl ether)
Substrate #7

O

O

O

O

O
O
O

Chi2/DoF

8.8076E-7

R2

0.92783

VMAX

0.009

+0.00098

KM (M)

7

+3

Kcat (s-1)

2.1E-5

+1E-6

O
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Fluorescein di(pivyloxymethyl ether) PVME
Substrate #8

O

O

O

O

O
O
O

Chi2/DoF

1.0878E-7

R2

0.999

VMAX

0.0273

+0.0004

KM (M)

10.6

+0.5

Kcat (s-1)

7.9E-5

+1E-6

O
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Fluorescein di(cyclobutanecarboxymethyl ether) CBME
Substrate #9

O

O

O

O

O
O
O

Chi2/DoF

4.8073E-6

R2

0.99463

VMAX

0.072

+0.002

KM (M)

4.2

+0.5

Kcat (s-1)

0.00020

+5E-6

O
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Fluorescein di(cyclopentanecarboxymethyl ether) CPME
Substrate #10

O

O

O

O

O
O
O

Chi2/DoF

1.1831E-6

R2

0.99218

VMAX

0.040

+0.002

KM (M)

29

+4.6

Kcat (s-1)

0.00011

+7E-6

O
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Fluorescein di(cyclohexanecarboxymethyl ether) CHME
Substrate #11

O

O

O

O

O
O
O

Chi2/DoF

2.4268E-7

R2

0.92584

VMAX

0.0048

+0.0007

KM (M)

11.9

+5.4

Kcat (s-1)

1.3E-5

+2E-6

O
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Fluorescein di(benzoyloxymethyl ether) BNME
Substrate #12

O

O

O

O

O
O
O

Chi2/DoF

9.2497E-9

R2

0.43231

VMAX

0.00007

+0.00003

KM (M)

-0.12

+0.02

Kcat (s-1)

2E-7

+8E-8

O
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Fluorescein di(pentafluorobenzoyloxymethyl ether) FBME
Substrate 13

F
F

F
F

F
O

F
F

O

O

O

O

Chi /DoF

1.4701E-7

R

0.99962

2

2

V

0.00007

+0.00003

K (M)

0.125

+0.005

K (s )

0.00042

+2E-5

MAX

M

cat

-1

O

F
O

O

F

F
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Fluorescein di(pentafluorophenacetoxymethyl ether) FPME
Substrate #14

F

F

F

O

F

F

O

O

O

F

4.5365E-7

R2

0.99597

VMAX

0.08

+0.02

KM (M)

188

+49

Kcat (s-1)

0.00023

+4E-5

F
O

O

F

F
F

O

Chi2/DoF

O
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Fluorescein di(trifluoropropionoxymethyl ether) TFME
Substrate #15

O

F 3C

O

O

O

O

0.00276

R2

0.95644

VMAX

0.9

+0.12

KM (M)

30

+11

Kcat (s-1)

0.0024

+3E-4

CF 3
O

O

Chi2/DoF

O

